SEC Form 4 · accession 0001104659-18-041511
LIGAND PHARMACEUTICALS INC · LGND
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Stephen L Sabba
Director
Period of report
Jun 19, 2018
Accepted (ET)
Jun 21, 2018 · 12:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000886163
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 19, 2018 | A | 493 | $0.00 | A | 26,856 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $76.77 | Jun 19, 2018 | A | 2,474 | A | — | Jun 19, 2028 | Common Stock | 2,474 | 2,474 | D |
| Non-Qualified Stock Option (right to buy)F3 | $113.50 | holding | — | — | — | — | May 25, 2027 | Common Stock | 2,456 | 2,456 | D |
Explanation of responses
- F1These securities, as represented in Column 5, include a grant of 493 restricted shares approved by the Board of Directors of the Company at the 2018 Meeting, which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date.
- F2These securities, as represented in Column 5, were acquired by a grant of 2,474 shares approved by the Board of Directors of the Company at the 2018 Meeting. That grant (a) vests in full on the earlier of (i) the date of the next annual meeting of the Company stockholders following the grant date or (ii) on the first anniversary of the grant date, and (b) will vest immediately (i) upon a change in control or a hostile takeover of the Company or (ii) the death or permanent disability of the grantee if still serving at that time.
- F3These securities were previously reported on a Form 4 for this Reporting Person filed on May 30, 2017, and are included on this Form 4 only to report that they are currently fully vested and exercisable.